ZUP1 and Parkinson disease: Considering that the pathogenesis of PD primarily involves abnormalities in the ubiquitin–proteasome system and the dysregulation of mitochondrial function, modulation of E3 ligases and DUB activity holds therapeutic potential for PD treatment.